Evidence map›Paper›PMID 23323561›Full record

ReviewTherapeutic delivery2012

Application of polysaccharides for surface modification of nanomedicines.

Kyung-Oh Doh, Yoon Yeo

Abstract readReview
In one paragraph

Review in Therapeutic delivery, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 85 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Kyung-Oh DohDepartment of Physiology, Yeungnam University, Daegu, Republic of Korea.
Yoon Yeo
Purdue University West Lafayette · USYeungnam University · KR

Funding

Peritumorally transformable nanoparticles for intraperitoneal chemotherapy of ovaR21CA135130 · NCI · PURDUE UNIVERSITY · PI YEO, YOON · 2009 to 2010
$364k
NCI NIH HHS R21 CA135130
6 · The paper itself

Abstract

Polysaccharides have been used in various biomedical applications due to availability and biocompatibility. In particular, polysaccharides have gained increasing interest in the development of functional nanomedicines as a component to provide a stealth function, improve interactions with target tissues or enable environment-responsive drug release. This review discusses recent advances in nanomedicine engineering based on polysaccharides with a specific emphasis on the rationale, applications and the remaining challenges.

Indexed as

NanomedicineChitosanChondroitin SulfatesHeparinHumansHyaluronic AcidNanoparticlesPolysaccharidesSurface PropertiesChitosanChondroitin SulfatesHeparinHyaluronic AcidPolysaccharides

Identifiers

PMID23323561
PMCPMC3578296
OpenAlexW2049357702

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.